Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.
29th June, 2023
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin
View this resource
The proximal tubule (PT) is the key nephron segment mediating renal drug elimination and is the primary site of drug induced nephrotoxicity However, current animal studies have proved poorly predictive of human outcome. To address this, there has been a recent upsurge in physiological relevant microphysiological systems (MPS) of PT to recapitulate differentiation and function in vitro. Here we present results from our recently developed aProximate MPSTM human PT platform (Patent No:G001336.GB), in which primary PT cells are subject to fluidic media flow and a shear stress between 0.1-2 dynes/cm2.
Download Now